Your browser doesn't support javascript.
loading
Promises and challenges of adoptive T-cell therapies for solid tumours.
Morotti, Matteo; Albukhari, Ashwag; Alsaadi, Abdulkhaliq; Artibani, Mara; Brenton, James D; Curbishley, Stuart M; Dong, Tao; Dustin, Michael L; Hu, Zhiyuan; McGranahan, Nicholas; Miller, Martin L; Santana-Gonzalez, Laura; Seymour, Leonard W; Shi, Tingyan; Van Loo, Peter; Yau, Christopher; White, Helen; Wietek, Nina; Church, David N; Wedge, David C; Ahmed, Ahmed A.
Affiliation
  • Morotti M; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Albukhari A; Department of Oncology, Ludwig Institute for Cancer Research Lausanne, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
  • Alsaadi A; Biochemistry Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Artibani M; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Brenton JD; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Curbishley SM; Functional Genomics of Ovarian Cancer Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Dong T; Advanced Therapies Facility and National Institute for Health Research (NIHR) Biomedical Research Centre, University of Birmingham, Birmingham, UK.
  • Dustin ML; Medical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Hu Z; Chinese Academy of Medical Sciences (CAMS) Oxford Institute, University of Oxford, Oxford, UK.
  • McGranahan N; Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
  • Miller ML; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Santana-Gonzalez L; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK.
  • Seymour LW; Cancer System Biology Group, Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Shi T; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Van Loo P; Gene Therapy Group, Department of Oncology, University of Oxford, Oxford, UK.
  • Yau C; Department of Gynecological Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • White H; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.
  • Wietek N; Division of Informatics, Imaging and Data Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.
  • Church DN; The Alan Turing Institute, London, UK.
  • Wedge DC; Patient Representative, Endometrial Cancer Genomics England Clinical Interpretation Partnership (GeCIP) Domain, London, UK.
  • Ahmed AA; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Br J Cancer ; 124(11): 1759-1776, 2021 05.
Article in En | MEDLINE | ID: mdl-33782566
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Immunotherapy, Adoptive / Neoplasms Type of study: Guideline Limits: Animals / Humans Language: En Journal: Br J Cancer Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Immunotherapy, Adoptive / Neoplasms Type of study: Guideline Limits: Animals / Humans Language: En Journal: Br J Cancer Year: 2021 Document type: Article Affiliation country: Country of publication: